Roivant Sciences ROIV Income Statement
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | ||
|---|---|---|---|---|---|---|
| $3.35M-19.0% | $4.14M-35.0% | $6.37M-38.1% | $10.29M-26.9% | $14.07M-21.3% | ||
| $178.11M-7.0% | $191.55M-8.8% | $210.14M-10.4% | $234.57M-9.2% | $258.38M+7.5% | ||
| $4.01M+135% | -$11.4M+49.5% | -$22.56M-23.1% | -$18.32M-70.9% | -$10.72M+44.1% | ||
| —— | $143.87M+42.5% | $100.96M+385% | $20.84M-62.2% | $55.19M— | ||
| —— | -$809.24M-116% | -$373.97M+23.8% | -$490.63M-185% | -$171.98M-599% | ||
| $1.29M+9.8% | $1.17M+60.5% | $729K-14.4% | $852K-6.5% | $911K+1.0% | ||
| $3.77M— | —— | —— | —— | —— | ||
| $0— | $0-100% | $112K-74.8% | $445K-42.5% | $774K-29.4% | ||
| $0— | $0— | $0— | $0-100% | $110.39M0.0% | ||
| $3.42M+126% | -$12.9M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$2.39M-1.4% | -$2.35M+34.3% | -$3.58M+17.9% | -$4.36M+23.5% | -$5.7M+25.3% | ||
| -$11.46M— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $770.24M+33.3% | $577.68M+50.0% | $385.12M+100% | $192.56M— | $0— | ||
| —— | —— | —— | -$746.95M+38.8% | -$1.22B-17.0% | ||
| —— | —— | —— | —— | —— | ||
| -$750.35M+1.2% | -$759.1M+1.4% | -$769.86M+9.5% | -$851.01M-1.4% | -$839.45M-8.3% | ||
| $8.28M-1.3% | $8.38M+10.8% | $7.57M+5.0% | $7.21M+5.3% | $6.84M+2.6% | ||
| —— | —— | -$33.18M-258% | -$9.27M-146% | -$3.76M+91.0% | ||
| —— | —— | —— | $853.14M-34.0% | $1.29B+29.6% | ||
| —— | —— | $14.52M+89.3% | $7.67M+66.8% | $4.6M+11.2% | ||
| $268.35M+16.8% | $229.76M+65.2% | $139.06M+79.7% | $77.38M+56.0% | $49.6M+23.1% | ||
| $346.17M-1.8% | $352.48M+6.4% | $331.17M+3.2% | $321.02M+11.1% | $289.03M+14.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Roivant Sciences's revenue?
- Roivant Sciences (ROIV) generated $8.3M in revenue over the trailing twelve months, down 71.6% year over year.
- Where does Roivant Sciences's income statement data come from?
- Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
